Response by Lewis and de Lemos to Letter Regarding Article, "racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study"

Alana A. Lewis, James A. De Lemos

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)E69-E70
JournalCirculation
Volume142
Issue number5
DOIs
StatePublished - Aug 4 2020

Funding

Dr de Lemos reports grant support from Roche Diagnostics and Abbott Diagnostics; reports consulting fees from Roche Diagnostics, Abbott Diagnostics, Ortho Clinical Diagnostics, Quidel Corporation, Novo Nordisk, Amgen, Regen-eron, and Esperion; and is a co-owner of a patent (US patent application number 15/309,754) titled “Methods for Assessing Differential Risk for Developing Heart Failure.” Dr Lewis has no relationships to disclose.

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this